Previous studies have implicated HMGCR in Alzheimer’s disease (AD) as a genetic modifier of risk and cognitive decline, comparable to APOE, the main cholesterol transporter in the brain [5, 26]. The gene discussed is HMGCR; the disease is early-onset autosomal dominant Alzheimer disease.